{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:54:57Z","timestamp":1781567697002,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xagr.2026.100647","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:49:35Z","timestamp":1775756975000},"page":"100647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hyperpyrexia with hemodynamic instability after sublingual misoprostol: case report and literature review"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4239-2395","authenticated-orcid":false,"given":"Paola A.","family":"Castellanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3074-0073","authenticated-orcid":false,"given":"Juan C.","family":"Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-6759","authenticated-orcid":false,"given":"Angie J.","family":"Acero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5584-8224","authenticated-orcid":false,"given":"V\u00edctor S.","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xagr.2026.100647_bib0001","doi-asserted-by":"crossref","DOI":"10.31744\/einstein_journal\/2020AO5029","article-title":"Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach","volume":"18","author":"Koch","year":"2019","journal-title":"Einstein (S\u00e3o Paulo)"},{"issue":"7","key":"10.1016\/j.xagr.2026.100647_bib0002","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1471-0528.2010.02564.x","article-title":"High fever following postpartum administration of sublingual misoprostol","volume":"117","author":"Durocher","year":"2010","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.xagr.2026.100647_bib0003","article-title":"Sublingual misoprostol-induced rhabdomyolysis and convulsions in postpartum hemorrhage: a case report and literature review","volume":"16","author":"Li","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.xagr.2026.100647_bib0004","first-page":"159","article-title":"Uses of misoprostol in obstetrics and gynecology","volume":"2","author":"Allen","year":"2009","journal-title":"Rev Obs Gynecol"},{"issue":"3","key":"10.1016\/j.xagr.2026.100647_bib0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ijgo.12181","article-title":"FIGO\u2019s updated recommendations for misoprostol used alone in gynecology and obstetrics","volume":"138","author":"Morris","year":"2017","journal-title":"Int J Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.xagr.2026.100647_bib0006","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0029-7844(97)00275-5","article-title":"Severe hyperthermia following oral misoprostol in the immediate postpartum period","volume":"90","author":"Chong","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.xagr.2026.100647_bib0007","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13104-017-2661-2","article-title":"Sublingual misoprostol and hyperpyrexia: case report with temperature curve","volume":"10","author":"Tolefac","year":"2017","journal-title":"BMC Res Notes"},{"issue":"9","key":"10.1016\/j.xagr.2026.100647_bib0008","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s40121-023-00865-3","article-title":"Misoprostol-induced fever and unnecessary antibiotic prescribing: a retrospective study","volume":"12","author":"Abu Esba","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.xagr.2026.100647_bib0009","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.18203\/2320-1770.ijrcog20163021","article-title":"Severe morbidity with sublingual misoprostol in a post-partum patient: a case report","author":"SunitaVerma","year":"2016","journal-title":"Int J Reprod Contracept Obs Gynecol Publ"},{"issue":"5","key":"10.1016\/j.xagr.2026.100647_bib0010","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/AOG.0b013e3182707341","article-title":"Risk of fever after misoprostol for the prevention of postpartum hemorrhage","volume":"120","author":"Elati","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.xagr.2026.100647_bib0011","first-page":"65","article-title":"Case report and literature review: hyperpyrexia as side effect following the administration of sub-lingual misoprostol in the management of post-partum hemorrhage","volume":"41","author":"Mart\u00ednez Pacheco","year":"2013","journal-title":"Colomb J Anesthesiol"},{"key":"10.1016\/j.xagr.2026.100647_bib0012","first-page":"64","article-title":"Watch out-severe hyperthermia with misoprostol!","volume":"18","author":"Siwatch","year":"2019","journal-title":"IOSR J Dent Med Sci"},{"issue":"1","key":"10.1016\/j.xagr.2026.100647_bib0013","first-page":"65","article-title":"Case report and literature review: Hyperpyrexia as side effect following the administration of sub-lingual misoprostol in the management of post-partum hemorrhage","volume":"41","author":"Mart\u00ednez Pacheco","year":"2013","journal-title":"Colomb J Anesthesiol"},{"key":"10.1016\/j.xagr.2026.100647_bib0014","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.18203\/2320-1770.ijrcog20163021","article-title":"Severe morbidity with sublingual misoprostol in a post-partum patient: a case report","author":"SunitaVerma","year":"2016","journal-title":"Int J Reprod Contracept Obs Gynecol Publ online"},{"key":"10.1016\/j.xagr.2026.100647_bib0015","article-title":"Misoprostol induced convulsion- a rare side effect of misoprostol","author":"Sharma","year":"2017","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.xagr.2026.100647_bib0016","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13104-017-2661-2","article-title":"Sublingual misoprostol and hyperpyrexia: case report with temperature curve","volume":"10","author":"Tolefac","year":"2017","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.xagr.2026.100647_bib0017","first-page":"64","article-title":"Watch out-severe hyperthermia with misoprostol!","volume":"18","author":"Siwatch","year":"2019","journal-title":"IOSR J Dent Med Sci"},{"issue":"3","key":"10.1016\/j.xagr.2026.100647_bib0018","doi-asserted-by":"crossref","first-page":"106","DOI":"10.14740\/jcgo918","article-title":"Severe hyperthermia with altered mental status after misoprostol administration: two case reports","volume":"12","author":"Lee","year":"2023","journal-title":"J Clin Gynecol Obs"},{"key":"10.1016\/j.xagr.2026.100647_bib0019","article-title":"Sublingual misoprostol-induced rhabdomyolysis and convulsions in postpartum hemorrhage: a case report and literature review","author":"Li","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.xagr.2026.100647_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1028-4559(09)60251-5","article-title":"Use of mifepristone and sublingual misoprostol for early medical abortion","volume":"45","author":"Lin","year":"2006","journal-title":"Taiwan J Obs Gynecol"},{"issue":"7","key":"10.1016\/j.xagr.2026.100647_bib0021","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1471-0528.2010.02564.x","article-title":"High fever following postpartum administration of sublingual misoprostol","volume":"117","author":"Durocher","year":"2010","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.xagr.2026.100647_bib0022","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5468\/ogs.2018.61.2.220","article-title":"Effectiveness and safety of sublingual misoprostol in medical treatment of the 1st trimester miscarriage: experience of off-label use in Korea","volume":"61","author":"Park","year":"2018","journal-title":"Obs Gynecol Sci"},{"issue":"2","key":"10.1016\/j.xagr.2026.100647_bib0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.contraception.2020.04.015","article-title":"Effectiveness of self-managed medication abortion between 13 and 24 weeks gestation: a retrospective review of case records from accompaniment groups in Argentina, Chile, and Ecuador","volume":"102","author":"Moseson","year":"2020","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.xagr.2026.100647_bib0024","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/tmi.13389","article-title":"High fever after sublingual administration of misoprostol for treatment of post-partum haemorrhage: a hospital-based, prospective observational study in Argentina","volume":"25","author":"Durocher","year":"2020","journal-title":"Trop Med Int Health"},{"issue":"4","key":"10.1016\/j.xagr.2026.100647_bib0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0010-7824(03)00024-6","article-title":"Sublingual misoprostol for preabortion cervical ripening in first-trimester pregnancy termination","volume":"67","author":"Vimala","year":"2003","journal-title":"Contraception"},{"issue":"11","key":"10.1016\/j.xagr.2026.100647_bib0026","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/humrep\/dei196","article-title":"A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12\u201320 weeks gestation","volume":"20","author":"Tang","year":"2005","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.xagr.2026.100647_bib0027","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2393-12-65","article-title":"Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?","volume":"12","author":"Le\u00f3n","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"10.1016\/j.xagr.2026.100647_bib0028","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4103\/0253-7613.81513","article-title":"Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise","volume":"43","author":"Kushwah","year":"2011","journal-title":"Indian J Pharmacol"},{"issue":"1","key":"10.1016\/j.xagr.2026.100647_bib0029","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00404-010-1590-2","article-title":"Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion","volume":"284","author":"Dahiya","year":"2011","journal-title":"Arch Gynecol Obs"},{"issue":"1","key":"10.1016\/j.xagr.2026.100647_bib0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/jrms.JRMS_393_19","article-title":"Comparison of the efficacy of sublingual, oral, and vaginal administration of misoprostol in the medical treatment of missed abortion during first trimester of pregnancy: a randomized clinical trial study","volume":"25","author":"Souizi","year":"2020","journal-title":"J Res Med Sci"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577826000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577826000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:30:36Z","timestamp":1781566236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577826000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666577826000456"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2026.100647","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperpyrexia with hemodynamic instability after sublingual misoprostol: case report and literature review","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2026.100647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100647"}}